Phse 2, Open LAbel, Single Arm Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Ticilimumab in Patients with Advanced Refractory and /or Relapsed Melanoma

  • Rinehart, John (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/063/31/07